Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lineage Cell Therapeutics (LCTX) Receivables - Other (2016 - 2025)

Lineage Cell Therapeutics (LCTX) has 12 years of Receivables - Other data on record, last reported at $671000.0 in Q4 2025.

  • For Q4 2025, Receivables - Other changed N/A year-over-year to $671000.0; the TTM value through Dec 2025 reached $671000.0, changed N/A, while the annual FY2025 figure was $671000.0, N/A changed from the prior year.
  • Receivables - Other reached $671000.0 in Q4 2025 per LCTX's latest filing, up from $549000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $671000.0 in Q4 2025 and bottomed at $200000.0 in Q2 2022.